Concepedia

Ronald Nahass

RN

Statistics

Publications

50

Citations

6.8K

H-Index

28

Active since

1988

Affiliations

Rutgers, The State University of New Jersey(Current)

Johnson University

Somerset Medical Center

Johns Hopkins University

Gilead Sciences (United States)

Ronald Nahass is an author at Rutgers, The State University of New Jersey specializing in infectious diseases, antiviral therapy, and viral hepatitis.

ORCID

Publications per year

1988–2023

50

Publications

50

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

, , +16

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Raymond T. Chung, Marc G. Ghany, Kristen Marks et al. · Clinical Infectious Diseases · 2018 · 726 citations · Full text

, , +16

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

, , +17

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Gregory J. Dore, Frederick L. Altice, Alain H. Litwin et al. · Annals of Internal Medicine · 2016 · 363 citations · Full text

, , +17

1–5 of 50